NGEN PE Ratio & Valuation, Is NGEN Overvalued

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NGEN competitors is 29535.63, providing a benchmark for relative valuation. NervGen Pharma Corp Corp (NGEN.O) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NGEN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NGEN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NGEN currently overvalued or undervalued?

NervGen Pharma Corp (NGEN) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of NervGen Pharma Corp (NGEN) is between -- to -- according to relative valuation method.

What is NervGen Pharma Corp (NGEN) fair value?

NGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of NervGen Pharma Corp (NGEN) is between -- to -- according to relative valuation method.

How does NGEN's valuation metrics compare to the industry average?

The average P/S ratio for NGEN's competitors is 29535.63, providing a benchmark for relative valuation. NervGen Pharma Corp Corp (NGEN) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for NervGen Pharma Corp (NGEN) as of Mar 11 2026?

As of Mar 11 2026, NervGen Pharma Corp (NGEN) has a P/B ratio of NaN. This indicates that the market values NGEN at NaN times its book value.

What is the current FCF Yield for NervGen Pharma Corp (NGEN) as of Mar 11 2026?

As of Mar 11 2026, NervGen Pharma Corp (NGEN) has a FCF Yield of NaN%. This means that for every dollar of NervGen Pharma Corp's market capitalization, the company generates NaN cents in free cash flow.

What is the current Forward P/E ratio for NervGen Pharma Corp (NGEN) as of Mar 11 2026?

As of Mar 11 2026, NervGen Pharma Corp (NGEN) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of NervGen Pharma Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for NervGen Pharma Corp (NGEN) as of Mar 11 2026?

As of Mar 11 2026, NervGen Pharma Corp (NGEN) has a Forward P/S ratio of NaN. This means the market is valuing NGEN at $NaN for every dollar of expected revenue over the next 12 months.

NGEN Valuation